Want to join the conversation?
As per the new collaboration agreement for metabolic immuno-oncology programs, $CELG and $AGIO said that the companies will share the cost and profit with a mix of 50/50. $AGIO is eligible for up to $169MM in clinical and regulatory milestone payments for each program. $CELG will lead ex-U.S. development and commercialization for all programs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?